FDA Inspection 1109549 — Sophien-Arzneimittel GmbH
The FDA completed an inspection of Sophien-Arzneimittel GmbH on Sep 5, 2019 in Koblenz. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 5, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Unapproved and Misbranded Drugs
- Location
- Koblenz (Germany)